CAS 78822-40-9: (2S,4R)-N-[2-chloro-1-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-4-ethyl-piperidine-2-carboxamide hydrochloride

Pirlimycin Hydrochloride, a Clindamycin analog, is a semi-synthetic lincosaminide antibiotic.

Stability Hygroscopic Applications Pirlimycin Hydrochloride (Mixture of Diastereomers) is a semi-synthetic lincosaminide antibiotic; structural analog of Clindamycin. Antibacterial. References Ahonkhai, V.I., et al.: Antimicrob. Agents Chemother., 21, 902 (1982); Qadri, S.M.H., et al.: J. Antibiot., 36, 42 (1983); Birkenmeyer, R.D., et al.: J. Med. Chem., 27, 216 (1984);

Applications Pirlimycin Hydrochloride is a semi-synthetic lincosaminide antibiotic. Pirlimycin Hydrochloride is a Clindamycin (C580115) is a semi-synthetic antibiotic prepared from Lincomycin. References Birkenmeyer, R., et al.: J. Med. Chem., 27, 216 (1984);

Pirlimycin HCl is an antibacterial product, which is a semi-synthetic derivative of the natural antibiotic lincomycin produced by Streptomyces lincolnensis. Its mode of action involves the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the elongation of peptide chains. This action is particularly effective against Gram-positive bacteria, including Staphylococcus and Streptococcus species. Pirlimycin HCl is primarily used in veterinary medicine, specifically for the treatment and control of clinical and subclinical mastitis in dairy cattle. Mastitis, an inflammation of the mammary gland, is typically caused by bacterial infections and can lead to decreased milk production and quality. By effectively targeting the causative bacteria, Pirlimycin HCl helps in reducing the incidence and severity of mastitis, thereby supporting the health and productivity of dairy herds.